Satyajit Patra

Satyajit Patra

Auto-generated profile, based on publicly available information

Satyajit Patra

Department of Biochemistry American International Medical University St. Lucia USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2016 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
SPSatyajit Patra
Satyajit Patra
VYVanesa Young
Vanesa Young

1 January 2015 in Translational Biomedicine
Verified
Journal Article
Open access
PDF file
SPSatyajit Patra
Satyajit Patra
SNS Nithya
S Nithya
BSB Srinithya
B Srinithya
MSMeenakshi Sm
Meenakshi Sm
Obesity is a complex health issue to address, it is a serious and chronic disease that can have a negative effect on many systems in your body. Overweight and obesity may increase the risk of many health problems, including diabetes, heart disease, osteoarthritis and certain cancers. Obesity is increasing at an alarming rate throughout the world. Today it is estimated that there are more than 300 million obese people world-wide. Obesity is regarded as a disorder of lipid metabolism and the enzymes involved in this process could be targeted selectively for the development of antiobesity drugs. However, most of the anti-obesity drugs that were approved and marketed have now been withdrawn due to serious adverse effects. The naturopathic treatment for obesity has been explored extensively since ancient times and gaining momentum in the present scenario. Traditional medicinal plants and their active phytoconstituents have been used for the treatment of obesity and their associated secondary complications. Some active medicinal plants and their respective bioactive compounds were also tested by clinical trials and are effective in traemnet of obesity. This review focus on natural phytoextracts with their mechanism of action and their preclinical experimental model for further scientific research.

1 May 2016 in International Immunopharmacology
Verified
Journal Article
Closed access
SPSatyajit Patra
Satyajit Patra
MMMeenakshi Sundaram Muthuraman
Meenakshi Sundaram Muthuraman
MMM. Meenu
M. Meenu
PPPadma Priya
Padma Priya
BPBrindha Pemaiah
Brindha Pemaiah

1 August 2017
Verified
Journal Article
Open access
PDF file
SPSatyajit Patra
Satyajit Patra
VYVanesa Young
Vanesa Young
LLLeslie Llewellyn
Leslie Llewellyn
JSJitendra Senapati
Jitendra Senapati
JMJesil Mathew
Jesil Mathew
Studies show that approximately 20% of all breast cancer patients have a breast tumor that tests positive for Human Epidermal Growth Factor Receptor 2, otherwise known as the HER2 gene. As such, treatments for breast cancer usually include drugs that target HER2. The drug Trastuzumab is a recombinant antibody that has been approved by the FDA for the treatment of these HER2 positive breast cancers. However, researchers have found that mutations in associated genes, PIK3CA and KRAS, can cause the tumor to become resistant to Trastuzumab. The purpose of this article is to evaluate the sensitivity of the cancer cell lines to the drug Trastuzumab and investigate how this sensitivity is compromised by the PIK3CA, KRAS and BRAF gene mutations. Trastuzumab responsiveness was evaluated in breast cancer cell lines by treating the lines with an optimal concentration of the drug followed by a proliferation assay of the cell lines in the presence of monoclonal antibodies. We determined the optimum concentration of Trastuzumab to be 7 μg/well. The BRAF and KRAS mutated cell line, MDA-MB-231, showed the least sensitivity after being treated with trastuzumab when compared to the sensitivity of the PIK3CA mutated cell lines, MCF-7 and MDA-MB-361, and the KRAS/ BRAF/ PIK3CA cell line, MDA-MB-453. Clinical observations show that mutations in BRAF and KRAS genes in breast cancer cells do lower the responsiveness of Trastuzumab drug treatments.

1 February 2011 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
KNKhue Vu Nguyen
Khue Vu Nguyen
RNRobert K. Naviaux
Robert K. Naviaux
SPSatyajit Patra
Satyajit Patra
BBBruce A. Barshop
Bruce A. Barshop
WNWilliam L. Nyhan
William L. Nyhan

1 January 2015 in Annals of Clinical and Laboratory Research
Verified
Journal Article
Open access
PDF file
SPSatyajit Patra
Satyajit Patra
AAAraromi Adewale Andrew
Araromi Adewale Andrew
Several works have been done on genetic engineering with major focus on its importance ranging from increasing plant and animal food production, diagnosing disease condition, improve medical treatment, and produce vaccines and other useful drugs. Methods in the techniques involve the selective breeding of animals and plants, hybridization (reproduction between different strains or species), and recombinant deoxyribonucleic acid (rDNA). However, these benefits are not without peril. This article gives a brief account on the effect of this principle on the biosphere together with several controversial issues that accompany the acceptance of this technology.